Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Plastic Surgery

Edition

30-Second Takeaway

  • Immune dysregulation in keloids highlights cytokine and checkpoint blockade as rational adjuncts to surgery and radiation.
  • Collagen-guided, scaffold-free adipose constructs may improve fat graft stability, integration, and regenerative signaling.
  • Silk fibroin and other nature-derived matrices target fibroblast senescence and oxidative stress, not just volume replacement.
  • Next-generation wound dressings for diabetic and oral wounds combine strong adhesion with immunomodulatory and pro-angiogenic functions.
  • Theranostic and adhesive bone biomaterials may reduce hardware dependence while enabling real-time monitoring of craniofacial repair.

Week ending January 24, 2026

Emerging biologic and biomaterial platforms for scars, soft tissue, bone, and complex wound reconstruction

Immune-centric model of keloids opens door to targeted biologic therapy

ADVANCES IN WOUND CAREJan 23, 2026

This review reconceptualizes keloids as an immune-driven disease rather than a purely fibroblast-mediated scar. Single-cell and multi-omics studies show enrichment of M2 macrophages, mast cells, Th2/Th17 cells, and dendritic cells sustaining fibroblast activation and fibrosis. Key profibrotic circuits involve TGF-β/Smad, IL-4/IL-13, IL-6/JAK-STAT3, and PI3K/AKT/mTOR pathways interacting with mechanical stress. Soluble HLA-E and tissue-resident memory T cells are highlighted as potential biomarkers of progression and postoperative relapse. Early clinical experience with dupilumab shows reduced lesion burden and pruritus, and multiple cytokine and checkpoint targets are in exploration. Translation is limited by a lack of robust keloid models and large trials, reinforcing the need for immune profiling in high-risk patients.

Scaffold-free, collagen-guided adipose constructs to stabilize soft-tissue volume

ACTA BIOMATERIALIAJan 23, 2026

This study reports a Self-Assembly Fat (SAF) construct derived from lipoaspirate via intrinsic type I collagen crosslinking. Exogenous collagen supplementation (SAF⁺) increased stiffness, elasticity, and cohesion while preserving handling for potential flap-like implantation. In vitro, SAF⁺ enhanced adipogenic differentiation and improved stem cell recruitment compared with unsupplemented constructs. In vivo, SAF⁺ accelerated soft-tissue repair by promoting M2 macrophage polarization, angiogenesis, and stem cell homing. Mechanistically, integrin α2β1–FAK/Src activation linked collagen network formation to a pro-regenerative microenvironment.

Silk fibroin injectable rejuvenates fibroblasts and ECM in aged skin models

BIOACTIVE MATERIALSJan 19, 2026

This work evaluates silk fibroin (SF) as an injectable scaffold targeting fibroblast senescence in aged skin. SF supported fibroblast adhesion and proliferation while decreasing senescence-associated secretory phenotype factors and restoring a more functional cell state. It reduced reactive oxygen species and matrix metalloproteinase expression via modulation of the ROS–MAPK–AP-1–MMP axis, slowing collagen degradation. SF restored ECM homeostasis through a non-inflammatory mechanism, contrasting with traditional fillers that rely on inflammatory collagen induction. These properties position SF as a candidate next-generation filler combining structural support with anti-senescent, pro-regenerative signaling.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Keloids and chronic wounds share macrophage and T-cell dysregulation, creating opportunities for targeted immunomodulation beyond steroids and debridement.
  • Autologous and protein-based matrices (collagen, silk, colostrum, polysaccharides) are being engineered to direct host regeneration, not merely fill space.
  • Scaffold architecture, degradation, and spatial drug release are key levers for synchronizing cartilage, bone, and soft-tissue repair.